{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:12:51Z","timestamp":1775754771318,"version":"3.50.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Australian Government Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,19]]},"DOI":"10.1093\/jpids\/piz073","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T08:13:33Z","timestamp":1570522413000},"page":"S15-S18","source":"Crossref","is-referenced-by-count":5,"title":["Live Attenuated Influenza Vaccines for Pandemic Preparedness"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1713-3056","authenticated-orcid":false,"given":"Kanta","family":"Subbarao","sequence":"first","affiliation":[{"name":"World Health Organization Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia"},{"name":"Department of Microbiology and Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,3,19]]},"reference":[{"key":"2020031907573315400_CIT0001","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1128\/JVI.63.11.4603-4608.1989","article-title":"Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics","volume":"63","author":"Kawaoka","year":"1989","journal-title":"J Virol"},{"key":"2020031907573315400_CIT0002","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF01314321","article-title":"Replication of avian influenza viruses in humans","volume":"119","author":"Beare","year":"1991","journal-title":"Arch Virol"},{"key":"2020031907573315400_CIT0003","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1126\/science.279.5349.393","article-title":"Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness","volume":"279","author":"Subbarao","year":"1998","journal-title":"Science"},{"key":"2020031907573315400_CIT0004","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(98)01182-9","article-title":"Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus","volume":"351","author":"Yuen","year":"1998","journal-title":"Lancet"},{"key":"2020031907573315400_CIT0005","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0140-6736(99)03311-5","article-title":"Human infection with influenza H9N2","volume":"354","author":"Peiris","year":"1999","journal-title":"Lancet"},{"key":"2020031907573315400_CIT0006","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1073\/pnas.0308352100","article-title":"Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome","volume":"101","author":"Fouchier","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020031907573315400_CIT0007","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(04)15595-5","article-title":"Re-emergence of fatal human influenza A subtype H5N1 disease","volume":"363","author":"Peiris","year":"2004","journal-title":"Lancet"},{"key":"2020031907573315400_CIT0008","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa040419","article-title":"Avian influenza A (H5N1) in 10 patients in Vietnam","volume":"350","author":"Tran","year":"2004","journal-title":"N Engl J Med"},{"key":"2020031907573315400_CIT0009","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N Engl J Med"},{"key":"2020031907573315400_CIT0010","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1473-3099(17)30323-7","article-title":"Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013\u201317: an epidemiological study of laboratory-confirmed case series","volume":"17","author":"Wang","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2020031907573315400_CIT0011","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/cit479","article-title":"Origin and molecular characteristics of a novel 2013 avian influenza A(H6N1) virus causing human infection in Taiwan","volume":"57","author":"Yuan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2020031907573315400_CIT0012","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.3201\/eid1012.040961","article-title":"Human illness from avian influenza H7N3, British Columbia","volume":"10","author":"Tweed","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"2020031907573315400_CIT0013","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0140-6736(14)60111-2","article-title":"Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study","volume":"383","author":"Chen","year":"2014","journal-title":"Lancet"},{"key":"2020031907573315400_CIT0014","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/JCM.23.1.66-72.1986","article-title":"Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine","volume":"23","author":"Clements","year":"1986","journal-title":"J Clin Microbiol"},{"key":"2020031907573315400_CIT0015","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1128\/JCM.28.11.2539-2550.1990","article-title":"Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults","volume":"28","author":"Gorse","year":"1990","journal-title":"J Clin Microbiol"},{"key":"2020031907573315400_CIT0016","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/JVI.01957-06","article-title":"Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines","volume":"81","author":"Sasaki","year":"2007","journal-title":"J Virol"},{"key":"2020031907573315400_CIT0017","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0022-3476(00)70097-7","article-title":"Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A\/Sydney) not contained in the vaccine","volume":"136","author":"Belshe","year":"2000","journal-title":"J Pediatr"},{"key":"2020031907573315400_CIT0018","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/01.inf.0000143643.44463.b1","article-title":"Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a\/Fujian\/411\/2002-like H3N2 antigenic variant strain","volume":"23","author":"Mendelman","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"2020031907573315400_CIT0019","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00019048-199305000-00003","article-title":"Use of live attenuated cold-adapted influenza A reassortant virus vaccines in infants, young adults, and elderly adults","volume":"2","author":"Murphy","year":"1993","journal-title":"Infect Dis Clin Pract"},{"key":"2020031907573315400_CIT0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/08828240260066242","article-title":"Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines","volume":"15","author":"Murphy","year":"2002","journal-title":"Viral Immunol"},{"key":"2020031907573315400_CIT0021","first-page":"181","article-title":"Live attenuated influenza vaccine","volume":"386","author":"Jin","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"2020031907573315400_CIT0022","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1586\/14760584.2014.922417","article-title":"Development of live attenuated influenza vaccines against pandemic influenza strains","volume":"13","author":"Coelingh","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"2020031907573315400_CIT0023","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/596558","article-title":"A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults","volume":"199","author":"Karron","year":"2009","journal-title":"J Infect Dis"},{"key":"2020031907573315400_CIT0024","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1016\/j.vaccine.2009.05.099","article-title":"Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults","volume":"27","author":"Karron","year":"2009","journal-title":"Vaccine"},{"key":"2020031907573315400_CIT0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fimmu.2015.00287","article-title":"Boosted influenza-specific T cell responses after H5N1 pandemic live attenuated influenza virus vaccination","volume":"6","author":"Peng","year":"2015","journal-title":"Front Immunol"},{"key":"2020031907573315400_CIT0026","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1016\/j.vaccine.2009.03.082","article-title":"A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a phase I trial in healthy adults","volume":"27","author":"Talaat","year":"2009","journal-title":"Vaccine"},{"key":"2020031907573315400_CIT0027","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1086\/590916","article-title":"Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A\/Vietnam\/1203\/2004 (H5N1) vaccine after priming with an antigenic variant","volume":"198","author":"Goji","year":"2008","journal-title":"J Infect Dis"},{"key":"2020031907573315400_CIT0028","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1473-3099(11)70240-7","article-title":"DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials","volume":"11","author":"Ledgerwood","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2020031907573315400_CIT0029","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(00)05066-2","article-title":"Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza","volume":"357","author":"Nicholson","year":"2001","journal-title":"Lancet"},{"key":"2020031907573315400_CIT0030","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S0264-410X(00)00395-9","article-title":"Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans","volume":"19","author":"Treanor","year":"2001","journal-title":"Vaccine"},{"key":"2020031907573315400_CIT0031","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0264-410X(02)00632-1","article-title":"Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A\/Duck\/Singapore\/97 vaccine in a primed human population","volume":"21","author":"Stephenson","year":"2003","journal-title":"Vaccine"},{"key":"2020031907573315400_CIT0032","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1016\/j.vaccine.2014.09.070","article-title":"Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine","volume":"32","author":"Babu","year":"2014","journal-title":"Vaccine"},{"key":"2020031907573315400_CIT0033","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/infdis\/jiu123","article-title":"A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response","volume":"209","author":"Talaat","year":"2014","journal-title":"J Infect Dis"},{"key":"2020031907573315400_CIT0034","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/infdis\/jiv526","article-title":"Evaluation of the safety and immunogenicity of a candidate pandemic live attenuated influenza vaccine (pLAIV) against influenza A(H7N9)","volume":"213","author":"Sobhanie","year":"2016","journal-title":"J Infect Dis"},{"key":"2020031907573315400_CIT0035","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/infdis\/jiv210","article-title":"High-affinity H7 head and stalk domain-specific antibody responses to an inactivated influenza H7N7 vaccine after priming with live attenuated influenza vaccine","volume":"212","author":"Halliley","year":"2015","journal-title":"J Infect Dis"},{"key":"2020031907573315400_CIT0036","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection","volume":"19","author":"Henry Dunand","year":"2016","journal-title":"Cell Host Microbe"},{"key":"2020031907573315400_CIT0037","article-title":"Intranasal live influenza vaccine priming elicits localized B cell responses in mediastinal lymph nodes","volume":"92:e01970-17","author":"Jegaskanda","year":"2018","journal-title":"J Virol"},{"key":"2020031907573315400_CIT0038","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.1128\/JVI.00425-14","article-title":"African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates","volume":"88","author":"Matsuoka","year":"2014","journal-title":"J Virol"},{"key":"2020031907573315400_CIT0039","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S1473-3099(17)30240-2","article-title":"Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A\/17\/turkey\/Turkey\/05\/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial","volume":"17","author":"Pitisuttithum","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2020031907573315400_CIT0040","first-page":"129","article-title":"Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/9\/Supplement_1\/S15\/32931575\/piz073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/9\/Supplement_1\/S15\/32931575\/piz073.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T11:57:48Z","timestamp":1584619068000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/9\/Supplement_1\/S15\/5810039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":40,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2020,3,19]]},"published-print":{"date-parts":[[2020,3,19]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piz073","relation":{},"ISSN":["2048-7207"],"issn-type":[{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3]]},"published":{"date-parts":[[2020,3]]}}}